DIRECT mAb THERAPY

• PROCESS OF DIRECT mAb THERAPY?

  1. Monoclonal antibodies designed with complementary binding site in shape to antigens outside cancer cells
  2. Monoclonal antibodies given to patient
  3. Attach to cancer cells
  4. Preventing chemicals (that enable uncontrolled cell division) from binding to cancer cells
  5. Prevents growth
• WHY DOES DIRECT mAb THERAPY NOT AFFECT NORMAL CELLS?

  can only attach to cancer cells